Expert Interview
A Second Opinion: Discussing the results from the Phase 2 Study of Vertex' suzetrigine for the treatment of painful lumbosacral radiculopathy
Ticker(s): VRTXInstitution: UC Davis Health Center
- Chief, Division of Pain Medicine, Clinical Professor, Division of Pain Medicine & Director, Cancer Pain Management & Supportive Care at UC Davis.
- Expertise in cancer pain management, craniofacial pain and complex regional pain syndrome.
- Research interests in health services administration, pain medicine education, responsible opioid management, targeted drug delivery, and the applied use of stem cells in the setting of intervertebral disc disease.
Can you please give us some background on your clinical practice and how many patients you manage pain for?
Added By: ben_adminWhat is your current standard of care for managing pain in your settings?
Added By: ben_adminCan you discuss the need for alternatives to opioids for pain management?
Added By: ben_adminWhat are your thoughts on the potential of Suzetrigine from Vertex?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
